Alibaba investors face Oct. 5 deadline to seek lead plaintiff role

  • Alibaba investors have until Oct. 5 to seek lead plaintiff appointment.
  • 4.7% further decline followed Alibaba ADSs on June 25, 2026.
  • The lawsuit alleges Alibaba and its Chief Executive Officer violated securities laws.

Investors who purchased Alibaba Group Holding Limited publicly traded securities during the June 26, 2025, to June 24, 2026, Class Period have until Monday, Oct. 5, 2026, to seek appointment as lead plaintiff in a proposed securities class action. The case, Wistisen v. Alibaba Group Holding Limited, No. 26-cv-06654, is pending in the U.S. District Court for the Southern District of New York and alleges that Alibaba and its Chief Executive Officer violated the Securities Exchange Act of 1934. The complaint alleges Alibaba failed to disclose its purported links to China’s Ministry of Industry and Information Technology, as well as risks involving adversarial distillation attacks against third-party AI models. Alibaba’s American Depositary Shares (ADSs) fell nearly 4% after the U.S. Department of Defense identified Alibaba on an updated Chinese military companies list on June 8, 2026, then declined 2.7% on June 24 and another 4.7% on June 25 after a Bloomberg report about Anthropic’s allegations. Robbins Geller says eligible investors can seek lead plaintiff status, although participation in any future recovery does not depend on holding that role.

本网站上的信息是使用AI生成的,我们无法保证其准确性。 请仅作为参考信息使用。